| BIO 2002 - the largest annual international meeting of the life science sector - is fast approaching, and is hosted this year, and for the third time in its history, by the city of Toronto in Ontario, Canada. Many in the life sciences in Europe and elsewhere in North America are aware of Canada's strengths in terms of its life science research base, pharmaceutical development expertise (within large pharma and contract development organisations), and some of the more interesting aspects of its intellectual property laws. However, perhaps less widely known is the extent to which federal and regional government support (structurally as well as financially), coupled with sharpening local and international investor interest have been shaping the development of several thriving biotechnology clusters. |
